Despite preserved cardiac function and decreased interstitial fibrosis, there was no significant decrease in cardiac hypertrophy (heart weight to tibia length ratio) with deletion of Acly in activated CFs (Fig. 3i). The gene discussed is ACLY; the disease is cardiac hypertrophy.